Expert advisers unanimously approve new Alzheimer’s drug despite safety risks
2024-06-11 10:20:06 - From: CHANNEL8
A panel of independent advisers overseeing the Food and Drug Administration unanimously sanctioned the latest experimental drug for Alzheimer's disease on Monday, emphasizing that its benefits outweigh the associated risks.
